These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1114 related articles for article (PubMed ID: 2510580)

  • 1. Structure-activity comparison of mitomycin C and mitomycin A analogues (review).
    Bradner WT; Remers WA; Vyas DM
    Anticancer Res; 1989; 9(4):1095-9. PubMed ID: 2510580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT; Rose WC; Schurig JE; Schlein A; Huftalen JB
    Cancer Res; 1984 Dec; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and antitumor activity of new mitomycin A analogues.
    Sami SM; Iyengar BS; Remers WA; Bradner WT
    J Med Chem; 1987 Jan; 30(1):168-73. PubMed ID: 3806593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems.
    Imai R; Morimoto M; Marumo H; Kobayashi T; Tsuruo T; Inaba M; Tsukagoshi S; Sakurai Y
    Gan; 1981 Dec; 72(6):944-9. PubMed ID: 6804296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551).
    Bradner WT; Catino JJ; Long BH; Rose WC; Schurig JE
    Anticancer Res; 1992; 12(3):959-64. PubMed ID: 1622154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of 7-N-phenyl derivatives of mitomycin C in the leukemia P388 system.
    Imai R; Ashizawa T; Urakawa C; Morimoto M; Nakamura N
    Gan; 1980 Aug; 71(4):560-2. PubMed ID: 7437130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anticancer efficacy by use of mitomycin C adsorbed on small activated carbon particles in mice.
    Hagiwara A; Takahashi T; Ueda T; Nakagawa Y
    Jpn J Cancer Res; 1987 Apr; 78(4):405-8. PubMed ID: 3108220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C analogues with secondary amines at position 7.
    Iyengar BS; Sami SM; Tarnow SE; Remers WA; Bradner WT; Schurig JE
    J Med Chem; 1983 Oct; 26(10):1453-7. PubMed ID: 6620304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advanced studies on mitomycins, antitumor activity and mode of action].
    Taguchi T; Morimoto M
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2396-409. PubMed ID: 3111386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic acetal derivatives of mitomycin C.
    Kaneko T; Wong H; Rose WC; Bradner WT; Doyle TW
    J Antibiot (Tokyo); 1990 Jan; 43(1):122-4. PubMed ID: 2307625
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and antitumor activity of additional mitomycin A analogues.
    Sami SM; Remers WA; Bradner WT
    J Med Chem; 1989 Mar; 32(3):703-8. PubMed ID: 2918519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitomycin C toxicity and pharmacokinetics in mice given sulfur nucleophiles.
    Dorr RT; Alberts DS; Liddil JD
    Anticancer Res; 1988; 8(4):733-7. PubMed ID: 3140711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
    Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
    Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
    Tsuruo T; Sudo Y; Asami N; Inaba M; Morimoto M
    Cancer Chemother Pharmacol; 1990; 27(2):89-93. PubMed ID: 2123421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antineoplastic activity of 1a-formyl and 1a-thioformyl derivatives of mitomycin C and 2-methylaziridine.
    Fishbein PL; Kohn H
    J Med Chem; 1987 Oct; 30(10):1767-73. PubMed ID: 3116255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the antitumor activity of M-16 and M-18, major metabolites of a new mitomycin C derivative KW-2149, in mice.
    Ashizawa T; Okamoto A; Okabe M; Kobayashi S; Arai H; Saito H; Kasai M; Gomi K
    Anticancer Drugs; 1995 Dec; 6(6):763-70. PubMed ID: 8845489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of 6-substituted mitosene analogues of the mitomycins.
    Casner ML; Remers WA; Bradner WT
    J Med Chem; 1985 Jul; 28(7):921-6. PubMed ID: 3925147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
    Bradner WT; Rose WC; Schurig JE; Florczyk AP
    Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 9-O-substituted derivatives of 9-hydroxy-5, 6-dimethyl-6H-pyrido[4,3-b]carbazole-1-carboxylic acid (2-(dimethylamino)ethyl)amide and their 10- and 11-methyl analogues with improved antitumor activity.
    Guillonneau C; PierréA ; Charton Y; Guilbaud N; Kraus-Berthier L; Léonce S; Michel A; Bisagni E; Atassi G
    J Med Chem; 1999 Jun; 42(12):2191-203. PubMed ID: 10377224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.